The benefits and risks of n-3 polyunsaturated fatty acids

Bioscience, Biotechnology and Biochemistry

Volumn 62, Issue 11, 1998, Pages 2079-2085

  Takahata, Kyoya ^a   Monobe, Kei Ichi ^a   Tada, Mikirou ^a   Weber, Peter C ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Benefits and risks; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; N 3 polyunsaturated fatty acids

Indexed keywords

OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; FORECASTING; HEALTH SURVEY; HUMAN; REFERENCE VALUE; REVIEW; RISK ASSESSMENT;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FORECASTING; HEALTH SURVEYS; HUMANS; REFERENCE VALUES; RISK ASSESSMENT;

ANIMALIA;

EID: 0032195637     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.62.2079     Document Type: Article

References (57)

1. Sprecher, H., Biochemistry of essential fatty acids. Prog. Lipid Res., 20, 13-22 (1981).
2. Glomset, J. A., Fish, fatty acids and human health. N. Engl. J. Med., 312, 1253-1254 (1985).
3. Lee, A. G., East, J. M., and Froud, R. J., Are essential fatty acids essential for membrane function? Prog. Lipid. Res., 25, 41-46 (1986).
4. Gill, I. and Valvety, R., Polyunsaturated fatty acids, part 1: Occurrence, biological activities and applications. TIB Tech., 15, 401-409 (1997).
5. Uauy, R., Treen, M., and Hoffman, D. R., Essential fatty acid metabolism and requirements during development. Semin. Per-natol., 13, 118-130 (1989).
6. Uauy, R. and Hoffman, D. R., Essential fatty acid requirements for normal eye and brain development. Semin. Pernatol., 15, 449-455 (1991).
7. Innis, S. M., Essential fatty acid in growth and development. Prog. Lipid. Res., 30, 39-103 (1991).
8. Simopoulos, A. P., Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54, 438-463 (1991).
9. Galli, C. and Simopoulos, A. P., Effects of fatty acids and lipids in health and disease. World Rev. Nutr. Diet., 76, 1-149 (1994).
10. Katan, M. B., Fish and heart disease. N. Engl. J. Med., 332, 1024-1025 (1995).
11. Kromhout, D., Bosschieter, E. B., and de Coulander, C. L., The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med., 312, 1205-1209 (1985).
12. Vollset, S. E., Heuch, L., and Bjelke, E., Fish comsumption and mortality from coronary heart disease. N. Engl. J. Med., 313, 820-821 (1985).
13. Curb, J. D. and Reed, D. M., Fish comsumption and mortality from coronary heart disease. N. Engl. J. Med., 313, 821-822 (1985).
14. Ascherio, A., Rimn, E. B., and Stampfer, M. J., Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary disease among men. N. Engl. J. Med., 332, 977-982 (1995).
15. Bang, H. O. and Dyerberg, J., Plasma lipids and lipoproteins in Greenlandic West-coast Eskimos. Acta. Med. Scand., 192, 85-94 (1972).
16. Bang, H. O. and Dyerberg, J., Lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv. Nutr. Res., 3, 1-21 (1986).
17. Uauy, R. D., Birch, D. G., Birch, E. E., Tyson, J. E., and Hoffman, D. R., Effect of dietary omega-3 fatty acids on retinal function of very-low-birth weight neonates. Pediatr. Res., 28, 485-492 (1990).
18. Hoffman, D. R. and Uauy, R. D., Essentialness of dietary omega-3 fatty acids for premature infants: plasma and red blood cell fatty acid composition. Lipids, 27, 886-895 (1992).
19. Birch, D. G., Birch, E. E., Hoffman, D. R., and Uauy, R., Retinal development in very-low-birth weight infants fed diets differing in omega-3 fatty acids. Invest. Ophthalmol. Vis. Sci., 33, 2365-2376 (1992).
20. Birch, E. E., Birch, D. G., Hoffman, D. R. and Uauy, R., Dietary essential fatty acid supply and visual acuity development. Invest. Ophthalmol. Vis. Sci., 33, 3242-3253 (1992).
21. Birch, E., Birch, D., Hoffman, D., Hale, L., and Uauy, R., Breast-feeding and optimal visual development. J. Pediatr. Ophthalmol. Strabismus., 30, 33-38 (1993).
22. Makrides, M., Simmer, K., Goggin, M., and Gibson, R. A., Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. Pediatr. Res., 33, 425-427 (1993).
23. Farquharson, J., Cockburn, F., Patrick, W. A., Jamieson, E. C., and Logan, R. W., Infant cerebral cortex phospholipid fatty acid composition and diet. Lancet, 340, 810-813 (1992).
24. Makrides, M., Neumann, M. A., Byard, R. W., Simmer, K., and Gibson, R. A., Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr., 60, 189-194 (1994).
25. Makrides, M., Neumann, M. A., Simmer, K., Pater, J., and Gibson, R. A., Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet, 345, 1463-1468 (1995).
26. Olsen, S. F., Sorensen, J. D., Secher, N. J., Hedegaard, M., Henriksen, T. B., Hansen, H. S., Grant, A., Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet, 339, 1003-1007 (1992).
27. Bairati, I., Roy, L., and Meyer, F., Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation, 85, 950-956 (1992).
28. Kaul, U., Sanghvi, S., Bahl, V. K., Dev, V., and Wasir, H. S., Fish oil supplements for prevention of restenosis after coronary angioplasty. Int. J. Cardiol., 35, 87-93 (1992).
29. Gapinski, J. P., VanRuiswyk, J. V., Heudebert, G. R., and Schectman, G. S., Preventing restenosis with fish oils following coronary angioplasty. Arch. Intern. Med., 153, 1595-1601 (1993).
30. Leaf, A., Jorgensen, M. B., Jacobs, A. K., Gote, G., Schoenfeld D. A., Scheer, J., Weiner, B. H., Slack, J. D., Kellett, M. A., and Raizner, A. E., Do fish oils prevent restenosis after coronary angioplasty? Circulation, 90, 2248-2257 (1994).
31. Bairati, I., Roy, L., and Meyer, F., Effects of fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease. Can. J. Cardiol., 8, 41-46 (1992).
32. Morris, M. C., Taylor, J. O., Stampfer, M. J., Rosner, B., and Sacks, F. M., The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am. J. Clin. Nutr., 57, 59-64 (1993).
33. Appel, L. J., Miller, E. R., Seidler, A. J., and Whelton, P. K., Does supplementation of diet with ‘fish oil’ reduced blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med., 153, 1429-1438 (1993).
34. Donadio, J. V. J., Bergstralh, E. J., Offord, K. P., Spencer, D. C., and Holley, K. E., A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N. Engl. J. Med., 331, 1194-1199 (1994).
35. Clark, W. F., Parbtani, A., Naylor, C. D., Levinton, C. M., Muirhead, N., Spanner, E., Huff, NM. W., Philbrick, D. J., and Holub, B. J., Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int., 44, 75-86 (1993).
36. De Caterina, R., Caprioli, R., Giannessi, D., Sicari, R., Galli, C., Lazzerini, G., Bernini, W., Carr, L., and Rindi, P., n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int., 44, 843-850 (1993).
37. Berthoux, F. C., Guerin, C., Burgard, G., Berthoux, P., and Alamartine, E., One-year randomized controlled trial with ome-ga-3 fatty acid-fish oil in clinical renal transplantation. Transplant Proc., 24, 2578-2582 (1992).
38. Homan van der Heide, J. J., Bilo, H. J., Donker, A. J., Wilmink, J. M., Sluiter, W. J., and Tegzess, A. M., The effect of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients. Transplantation, 54, 257-263 (1992).
39. Homan van der Heide, J. J., Bilo, H. J., Donker, J. M., Wilmink, J. M., and Tegzess, A. M., Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N. Engl. J. Med., 329, 769-773 (1993).
40. Diskin, C. J., Stokes, T. J. J., and Pennell, A. T., Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. Nephron, 64, 1-26 (1993).
41. Kjeldsen-Kragh, J., Lund, J. A., Riise, T., Finnanger, B., Haaland, K., Finstad, R., Mikkelsen, K., and Forre, O., Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J. Rheumatol., 19, 1531-1536 (1992).
42. Skoldstam, L., Borjesson, O., Kjallman, A., Seiving, B., and Akesson, B., Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand. J. Rheumatol., 21, 178-185 (1992).
43. Nielsen, G. L., Faarvang, K. L., Thomsen, B. S., Teglbjaerg, K. L., Jensen, L. T., Hansen, T. M., Lervang, H. H., Schmidt, E. B., Dyerberg, J., and Ernst, E., The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur. J. Clin. Invest., 22, 687-691 (1992).
44. Geusens, P., Wouters, C., Nijs, J., Jiang, Y., and Dequeker, J., Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum., 37, 824-829 (1994).
45. Soyland, E., Funk, J., and Rajka, G., Effects of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N. Engl. J. Med., 328, 1812-1816 (1993).
46. Berth-Jones, J. and Graham-Brown, R. A., Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet, 341, 1557-1560 (1993).
47. Horrobin, D. F., Fatty acid metabolism in health and disease: the role of delta-6-desaturase. AM. J. Clin. Nutr., 57, 732S-736S (1993).
48. Willis, A. L., In “Present knowledge in nutrition”, eds. Olson, R. E, The Nutrition Foundation, Washington, DC, pp. 90-113 (1984).
49. Garrido, A., Garrido, F., Guerra, R., and Valenzuela, A., Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids, 24, 833-835 (1989).
50. Garrido, A., Garate, M., Campos, R., Villa, A., Nieto, S., and Valenzuela, A., Increased susceptibility of cellular membranes to the induction of oxidative stress is observed after ingestion of high doses of fish oil: effect of aging and protective action of dl-a tocopherol supplementation. Nutr. Biochem., 4, 118-122 (1993).
51. Oski, F. A. and Barness, L. A., Vitamin E deficiency: a previously unrecognized cause of hemolytic anemia in the premature infant. J. Pediatr., 70, 211-220 (1967).
52. Sosenko, I. R. S., Innis, S. M., and Frank, L., Menhaden fish oil, n-3 polyunsaturated fatty acids, and protection of newborn rats from oxygen toxicity. Pediatr. Res., 25, 399-404 (1989).
53. Buch, R. A., Reme, C. A., and Malnoe, A., Light damage in the rat retina: the effect of dietary deprivation of n-3 fatty acids on acute structural alterations. Exp. Eye Res., 53, 741-752 (1991).
54. Arnold, R. W., Retinopathy of prematurity in Alaska. Proc. 19th. Ann. Providence Hos. Perinatal Sympo., Anchorage, AL, March (1992).
55. Woo, C. K. W. and Draper, FI. H., Vitamin E status of Alaskan Eskimos. Am. J. Clin. Nutr., 28, 808-813 (1975).
56. Dyerburg, J. and Bang, H. O., Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet, 2, 433-435 (1979).
57. Uauy, R., Hoffman, D. R., Birch, E. E., Birch, D. J., Jameson, D. M., and Tyson, J., Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: soy oil and marine oil supplementation of formula. J. Pediatr., 124, 612-620 (1994).